Patents by Inventor Eugene Lapinet

Eugene Lapinet has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4208406
    Abstract: Composition for treatment or prevention of skin, eye or mucosal inflammation in human and animals, especially but not exclusively by external topical application comprising an effective amount of a cyclic nucleotide derivative having the following structural formula: ##STR1## wherein R.sub.1 and R.sub.2, either are both a butyryl radical or one stands for a hydrogen atom and the other for a butyryl radical or both hydrogen atom; this compound may be used as such or in the form of any pharmaceutically acceptable salt of the same.The compounds of the general formula are 3', 5' adenosine monophosphate of cAMP derivatives.
    Type: Grant
    Filed: July 14, 1977
    Date of Patent: June 17, 1980
    Inventors: Eugene Lapinet, Georges Cehovic, Theodore Posternak
  • Patent number: 3978213
    Abstract: Methods and compositions designed for dermatological and cosmetic use containing as an active ingredient, cyclic 3',5'-adenosine monophosphate and salts thereof and optionally, a phosphodiesterase inhibitor such as theophylline.
    Type: Grant
    Filed: January 3, 1975
    Date of Patent: August 31, 1976
    Assignee: Nelson Research & Development Company
    Inventors: Eugene Lapinet, Georges D. Cehovic, Theodore Z. Posternak